• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

A Review of literature on Ischemic Heart Disease and Risk of Development of Cognitive Disorders

    PrajnaTeja D

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 1188-1200

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: A Review of literature on Ischemic Heart Disease and Risk of Development of
Cognitive Disorders
Methods: The literature search was conducted in Medline, Embase, PsycINFO, and
CINAHL. The search string consisted of predictor-related terms (e.g. myocardial
infarction, angina pectoris), outcome-related terms (e.g. dementia, Alzheimer, cognition),
as well as some specific limitations. All publications until 2021 were included if they
fulfilled the following eligibility criteria: 1) MI, AP, or a CHD variable that is a
combination of MI and AP (e.g. ischemic heart disease (IHD)) as predictor variable; 2)
cognition, cognitive impairment or dementia as outcome; 3) population-based study; 4)
prospective (≥1 year follow-up), cross-sectional or case-control study design; 5) ≥100
participants; and 6) aged ≥45 years. Reference lists of publications and secondary
literature were hand-searched for possible missing articles.
Results: The search yielded 3500 abstracts, of which (number***) were included in this
study. This resulted in 5 cross-sectional studies, 3 case-control studies, 6 prospective cohort
studies and 1 study with both cross-sectional and prospective analyses (designated as crosssectional
regarding study quality). Quality assessment of all 15 included studies was
sufficient (overall mean NOS score = 6.7, SD = 1.30, range = 3–10). Separate analyses for
each study design showed similar results for prospective (mean NOS score = 6.92, SD =
1.14, range = 5–9) and cross-sectional studies (mean NOS score = 7.23, SD = 0.98, range =
6–8), but the quality of case-control studies was somewhat lower (mean NOS score = 5.9,
SD = 1.93, range = 3–7), mainly due to the effects of one particular study with a score of 3.
Conclusion: We concluded that the CHD was associated with an increased risk of
cognitive impairment or dementia in prospective cohort studies. More mechanistic studies
are needed that focus on the underlying biological pathways (e.g. left ventricular
dysfunction, cerebral small vessel disease, hypoperfusio
Keywords:
    Coronary heart disease (CHD) atherosclerosis Cognitive impairments Dementia middle age old age and senile patients Acute myocardial infarction(AMI) Percutaneous coronary intervention (PCI) Coronary artery bypass grafting (CABG
  • PDF (181 K)
  • XML
(2021). A Review of literature on Ischemic Heart Disease and Risk of Development of Cognitive Disorders. European Journal of Molecular & Clinical Medicine, 8(4), 1188-1200.
PrajnaTeja D. "A Review of literature on Ischemic Heart Disease and Risk of Development of Cognitive Disorders". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 1188-1200.
(2021). 'A Review of literature on Ischemic Heart Disease and Risk of Development of Cognitive Disorders', European Journal of Molecular & Clinical Medicine, 8(4), pp. 1188-1200.
A Review of literature on Ischemic Heart Disease and Risk of Development of Cognitive Disorders. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 1188-1200.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 255
  • PDF Download: 194
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus